Nidan Laboratories & Healthcare Ltd
Diversified Consumer Services | Small Cap
Nidan Laboratories & Healthcare Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, suggesting a solid foundation. Its liquidity position is also reasonably good, indicating the company's ability to meet its short-term obligations. However, growth metrics and financial ratios reveal causes for concern, highlighting potential challenges in revenue and earnings sustainability. The company's efficiency needs improvement, particularly in fixed asset and capital turnover. While the company shows strengths in managing debt and generating profits, addressing the identified weaknesses is crucial for ensuring long-term financial health and stability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.80
- Financial Ratio4.00
- Profitability Ratio9.60
- Efficiency Ratio7.00
- Coverage Ratio4.40
- Solvency Ratio10.00
- Liquidity Ratio7.56
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursBearish
- 4 HoursBearish
- 1 DayStrong Bearish
- 1 WeekNeutral
- 1 MonthNeutral
Nidan Laboratories & Healthcare Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, suggesting a solid foundation. Its liquidity position is also reasonably good, indicating the company's ability to meet its short-term obligations. However, growth metrics and financial ratios reveal causes for concern, highlighting potential challenges in revenue and earnings sustainability. The company's efficiency needs improvement, particularly in fixed asset and capital turnover. While the company shows strengths in managing debt and generating profits, addressing the identified weaknesses is crucial for ensuring long-term financial health and stability.
Overall Valuation Score
P/E RATIO (TTM)
12.50
Industry Median
47.76
Small Cap Median
45.36
P/E RATIO
12.39
P/B RATIO
0.27
Industry Median
4.54
Small Cap Median
3.95
P/S RATIO
0.74
Industry Median
3.59
Small Cap Median
2.22
Others
PEG RATIO
0.00
EV/EBITDA RATIO
3.26
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹13.5 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth ratios present a mixed picture of the company's performance. Revenue and asset growth is encouraging, suggesting expansion in operations and asset base. However, the negative Operating Profit Growth Rate, EPS Growth, and Net Income Growth Rate raise concerns about the sustainability of earnings. While the company is growing, its profitability is declining, which needs to be addressed for long-term viability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 45.53 | -18.17 | -0.37 | 1.45 | 4.12 |
| Operating Profit Growth Rate | 5.85 | -27.74 | -5.29 | -21.43 | -4.35 |
| Earnings Per Share (EPS) Growth | -17.67 | 33.51 | -190.98 | -161.21 | -23.24 |
| Asset Growth Rate | 64.64 | -4.61 | -2.19 | 0.47 | 1.28 |
| Net Income Growth Rate | 15.65 | 33.08 | -191.24 | -161.3 | -23.74 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios suggest areas of concern. Low Adjusted EPS, Cash EPS, and Book Value Per Share indicate challenges in generating earnings and building equity value for shareholders. The company has not provided dividend. However, high Capital Expenditures (CapEx) shows investments in long-term assets. Improving earnings and shareholder value should be a priority.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 1.77 | 2.4 | -0.01 | 1.41 | 1.27 |
| Cash Earnings Per Share (Cash EPS) | 3.81 | 4.78 | -0.26 | 3.16 | 2.45 |
| Book Value Per Share | 47.41 | 49.96 | 47.63 | 49.05 | 50.14 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 6.5 | 0 | 0.6 | 0.9 | 0.5 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios are generally strong, indicating the company's ability to generate profits from its operations. High Gross Profit Margin, ROCE, ROE, and Operating Margin suggest efficient cost management and effective utilization of capital. However, a moderate ROA indicates that the company's assets could be used more efficiently to generate profits. Maintaining and improving these ratios is crucial for sustained profitability.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.86 | 15.25 | 14.76 | 10.8 | 11.51 |
| Return on Capital Employed (ROCE) | 10.09 | 8.17 | 7.95 | 6.17 | 5.99 |
| Return on Equity (ROE) | 4.04 | 5.1 | -4.88 | 2.9 | 2.17 |
| Return on Assets (ROA) | 10.64 | 8.06 | 7.8 | 6.1 | 5.76 |
| Operating Margin | 31.73 | 28.02 | 26.63 | 20.63 | 18.95 |
| Net Margin | 8.97 | 14.59 | -13.36 | 8.07 | 5.91 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed view of the company's operational performance. While the Inventory Turnover Ratio and Receivable Turnover Ratio are strong, indicating efficient inventory and receivables management, the Fixed Asset Turnover Ratio and Capital Turnover Ratio are low. This suggests the company is not generating substantial revenue from its fixed assets and capital investments. Optimizing asset utilization could lead to improved overall efficiency.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.45 | 1.13 | 1.35 | 1.5 | 1.71 |
| Inventory Turnover Ratio | 138.67 | 69.73 | 61.52 | 51.48 | 41.85 |
| Receivables Turnover Ratio | 5.5 | 4.26 | 7.38 | 27.41 | 14.64 |
| Days Sales in Inventory Ratio | 2.63 | 5.23 | 5.93 | 7.09 | 8.72 |
| Receivable Days | 66.36 | 85.68 | 49.46 | 13.32 | 24.93 |
| Capital Turnover Ratio | 0.39 | 0.33 | 0.34 | 0.34 | 0.35 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios indicate the company's ability to meet its interest and dividend obligations. The Interest Coverage Ratio is average, suggesting that the company can meet its interest expenses, but with limited cushion. The Equity Dividend Coverage Ratio is low, since company has not given dividend, indicating that the company might face challenges in meeting its dividend payments if it has to. Enhancing profitability and cash flow could improve these ratios.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 2.7 | 3.17 | -0.09 | 2.29 | 2.24 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency ratios paint a positive picture of the company's long-term financial health. The low Debt Ratio and Debt to Equity Ratio, coupled with a high Equity Ratio, suggest a conservative capital structure with minimal reliance on debt. The low Debt To Asset Ratio further confirms that the company's assets are primarily financed by equity. This strong solvency position reduces financial risk and provides a stable foundation for future growth.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.12 | 0.06 | 0.06 | 0.05 | 0.05 |
| Debt to Equity Ratio | 0.14 | 0.06 | 0.06 | 0.05 | 0.05 |
| Equity Ratio | 0.88 | 0.94 | 0.94 | 0.95 | 0.95 |
| Debt To Asset Ratio | 0.11 | 0.06 | 0.05 | 0.05 | 0.04 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position shows a mixed bag. Current and Quick Ratios are strong, reflecting a good ability to cover short-term liabilities with current assets. However, the Cash Ratio suggests a lower proportion of cash and cash equivalents relative to current liabilities. The negative Operating Cash Flow Ratio indicates challenges in generating cash from operations. While short-term obligations can likely be met, there's room to enhance cash management.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 4.88 | 6.18 | 5.36 | 4.27 | 4.59 |
| Quick Ratio | 4.86 | 6.15 | 5.34 | 4.22 | 4.54 |
| Cash Ratio | 0.62 | 0.83 | 0.24 | 0.17 | 0.19 |
| Operating Cash Flow Ratio | 0.59 | 1.08 | 0.46 | 0.21 | 0.16 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Nidan Laboratories & Healthcare Ltd | 6.32 | 12.39 | Neutral | 4.84 | 1.08 | 1.51 |
| 2 | Aatmaj Healthcare Ltd | 6.29 | 64.52 | Undervalued | 2.36 | 0.32 | 0.71 |
The management of Nidan Laboratories & Healthcare exhibits a mixed performance. Profit growth has been strong over the past 5 years, and working capital management shows improved efficiency. However, sales growth has been inconsistent over the past 3 years, and promoter holding has decreased significantly. Overall, the management demonstrates both strengths and weaknesses, requiring careful monitoring of strategic decisions and their impact.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Profit Growth | 23% (5 Years) | Profit growth has been strong over the past 5 years. |
| Working Capital Days | 94.04 (Mar 2025) | Working capital management shows improved efficiency. | |
| CONS | Sales Growth | -6% (3 Years) | Sales growth has been inconsistent over the past 3 years. |
| Promoter Holding | 57.04% (Mar 2025) | Promoter holding has decreased significantly. |
Financial Performance & Growth
Nidan Laboratories exhibits inconsistent financial performance. Sales growth has been volatile, with a 3-year compounded sales growth of -6%, although TTM sales growth is at 1%. Profit growth is strong at 23% over 5 years but declines to -7% over 3 years. Quarterly sales fluctuate, indicating instability. The operating profit margin (OPM) also varies, with a recent decrease to 17.58% in Mar 2025. This mixed performance suggests potential challenges in maintaining consistent revenue and profitability.
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Sales Growth % | 6.68% | -4.81% | 45.53% | -18.17% | -0.37% | 1.45% | |
| OPM % | 39.06% | 35.64% | 43.62% | 31.73% | 28.02% | 26.63% | 17.58% |
Capital Efficiency & Returns
Capital efficiency and returns for Nidan Laboratories are concerning. The current ROCE is -0.24% and ROE is -4.77% indicating poor returns on capital employed and equity. The ROCE has generally declined over the years.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE % | 10.13% | 13.99% | 10.09% | 8.17% | 7.95% | 6.20% |
Financial Health & Prudence
Nidan Laboratories shows moderate financial health. The company's borrowings have fluctuated, with recent data showing borrowings at ₹ 11.12 Cr. in Mar 2025. The company does not have a dividend payout. Overall, financial health requires careful monitoring due to fluctuations in profitability and borrowing levels.
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Borrowings (₹ Cr.) | 32.16 | 34.35 | 38.04 | 19.29 | 10.93 | 12.44 | 11.12 |
Shareholding & Ownership Structure
The shareholding pattern of Nidan Laboratories indicates a potential concern due to the decreasing promoter holding. Promoter holding has decreased from 71.22% in Mar 2023 to 57.04% in Mar 2025. This reduction could signal a lack of confidence from the promoters or strategic decisions to dilute their stake, which might negatively influence investor sentiment.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding % | 71.22% | 71.22% | 57.04% | 57.04% |
The risk assessment for Nidan Laboratories & Healthcare suggests a moderate level of concern due to segment performance volatility and inconsistent financial performance. Close monitoring of operational performance and strategic adjustments are necessary to mitigate risks and ensure stability.
Segment performance volatility
Nidan Laboratories exhibits segment performance volatility, as evidenced by fluctuations in quarterly sales and net profit. Sales have varied from ₹ 10.18 Cr. to ₹ 14.09 Cr., while net profit has seen significant swings, including a negative value of ₹ -5.15 Cr. in Mar 2024. These inconsistencies indicate potential instability in the company's operations and market conditions.
| Metric | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Sales (₹ Cr.) | 13.14 | 14.09 | 10.18 | 11.82 | 12.35 | 10.53 | 13.99 |
| Net Profit (₹ Cr.) | 0.86 | 2.32 | 1.22 | 1.92 | -5.15 | 1.10 | 0.88 |
Accounting quality red flags
There is fluctuation in other income contribution. The other income significantly fluctuates, with a notable negative value of ₹ -5.29 Cr in Mar 2024, which raises concerns about the consistency and reliability of earnings from non-core activities. This inconsistent reliance on other income could distort the true picture of the company's operational performance.
| Metric | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Other Income (₹ Cr.) | 0.39 | 0.33 | 3.00 | 1.52 | -5.29 | 1.03 | 1.22 |
Foreign exchange or interest rate exposure
The company's profit is affected by significant fluctuations in other income, as demonstrated by a notable shift to ₹ -3.76 Cr in Mar 2024 and a subsequent increase to ₹ 2.25 Cr in Mar 2025. Such volatility introduces unpredictability in financial forecasting and may impact investor confidence.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Other Income (₹ Cr.) | 0.37 | 0.01 | 1.06 | 0.40 | 3.33 | -3.76 | 2.25 |
Regulatory compliance cost trends
Employee costs as a percentage of sales have increased from 12% in Mar 2019 to 18% in Mar 2025. This increase suggests potential challenges in managing operational expenses.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Employee Cost % | 12% | 13% | 14% | 12% | 21% | 19% | 18% |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 1013.58Bearish
- SMA 2013.74Bearish
- SMA 5013.77Bearish
- EMA 1013.58Bearish
- EMA 2013.66Bearish
- EMA 5013.78Bearish
- DEMA 1013.47Bullish
- DEMA 2013.55Bearish
- DEMA 5013.61Bearish
- TEMA 1013.44Bullish
- TEMA 2013.50Bullish
- TEMA 5013.58Bearish
- MACD-0.09Bearish
- ADX17.08Weak Trend
- IndicatorValueSignal
- RSI34.45Neutral
- CCI-89.22Neutral
- ROC 9-2.88Bearish
- ROC 14-2.88Bearish
- ROC 25-1.46Bearish
- Stoch K0.00Oversold
- Stoch D0.00Oversold
- IndicatorValueSignal
- BB Upper14.13Neutral
- BB Middle13.74Neutral
- BB Lower13.35Neutral
- ATR0.06Low Volatility
- IndicatorValueSignal
- MFI0.00Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1013.70Bearish
- SMA 2013.74Bearish
- SMA 5013.88Bearish
- EMA 1013.63Bearish
- EMA 2013.72Bearish
- EMA 5013.87Bearish
- DEMA 1013.52Bearish
- DEMA 2013.60Bearish
- DEMA 5013.66Bearish
- TEMA 1013.47Bullish
- TEMA 2013.57Bearish
- TEMA 5013.62Bearish
- MACD-0.10Bearish
- ADX18.92Weak Trend
- IndicatorValueSignal
- RSI38.05Neutral
- CCI-97.03Neutral
- ROC 9-2.88Bearish
- ROC 14-0.37Bearish
- ROC 25-3.57Bearish
- Stoch K2.90Oversold
- Stoch D3.86Oversold
- IndicatorValueSignal
- BB Upper14.12Neutral
- BB Middle13.74Neutral
- BB Lower13.37Neutral
- ATR0.12Low Volatility
- IndicatorValueSignal
- MFI75.52Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1013.72Bearish
- SMA 2013.74Bearish
- SMA 5014.03Bearish
- EMA 1013.69Bearish
- EMA 2013.80Bearish
- EMA 5014.02Bearish
- DEMA 1013.59Bearish
- DEMA 2013.62Bearish
- DEMA 5013.70Bearish
- TEMA 1013.55Bearish
- TEMA 2013.59Bearish
- TEMA 50N/AN/A
- MACD-0.13Bearish
- ADX16.58Weak Trend
- IndicatorValueSignal
- RSI40.65Neutral
- CCI-127.88Oversold
- ROC 9-1.46Bearish
- ROC 14-3.57Bearish
- ROC 25-3.57Bearish
- Stoch K4.35Oversold
- Stoch D15.94Oversold
- IndicatorValueSignal
- BB Upper14.10Neutral
- BB Middle13.74Neutral
- BB Lower13.39Neutral
- ATR0.24Low Volatility
- IndicatorValueSignal
- MFI26.43Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1013.78Bearish
- SMA 2014.06Bearish
- SMA 5014.37Bearish
- SMA 10015.30Bearish
- SMA 20017.24Bearish
- EMA 1013.78Bearish
- EMA 2013.96Bearish
- EMA 5014.46Bearish
- EMA 10015.39Bearish
- EMA 20017.18Bearish
- DEMA 1013.60Bearish
- DEMA 2013.66Bearish
- DEMA 5013.57Bearish
- DEMA 10013.58Bearish
- DEMA 20013.56Bearish
- TEMA 1013.56Bearish
- TEMA 2013.63Bearish
- TEMA 5013.68Bearish
- TEMA 10013.46Bullish
- TEMA 20013.76Bearish
- MACD-0.23Bearish
- ADX14.21Weak Trend
- IndicatorValueSignal
- RSI40.36Neutral
- CCI-130.68Oversold
- ROC 14-7.22Bearish
- ROC 25-4.93Bearish
- Stoch K24.76Neutral
- Stoch D31.66Neutral
- IndicatorValueSignal
- BB Upper14.85Neutral
- BB Middle14.07Neutral
- BB Lower13.28Neutral
- ATR0.48Low Volatility
- IndicatorValueSignal
- MFI23.52Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2015.20Bearish
- SMA 5017.56Bearish
- EMA 2015.29Bearish
- EMA 5017.63Bearish
- DEMA 2013.78Bullish
- DEMA 5013.66Bullish
- TEMA 2013.68Bullish
- TEMA 5013.98Bearish
- MACD-1.11Bullish
- ADX33.70Strong Trend
- IndicatorValueSignal
- RSI39.91Neutral
- CCI-121.06Oversold
- ROC 14-16.27Bearish
- ROC 25-26.84Bearish
- Stoch K29.22Neutral
- Stoch D28.74Neutral
- IndicatorValueSignal
- BB Upper17.51Neutral
- BB Middle15.20Neutral
- BB Lower12.90Neutral
- ATR1.62Low Volatility
- IndicatorValueSignal
- MFI27.77Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 615.39Bearish
- SMA 1217.66Bearish
- SMA 2422.53Bearish
- EMA 615.61Bearish
- EMA 1217.64Bearish
- EMA 2421.94Bearish
- DEMA 613.99Bullish
- DEMA 1213.75Bullish
- DEMA 2413.65Bullish
- TEMA 614.08Bullish
- TEMA 1213.97Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX11.37Weak Trend
- IndicatorValueSignal
- RSI37.94Neutral
- CCI-126.40Oversold
- ROC 25-50.34Bearish
- ROC 50-56.17Bearish
- Stoch K11.33Oversold
- Stoch D11.56Oversold
- IndicatorValueSignal
- BB Upper29.64Neutral
- BB Middle20.12Neutral
- BB Lower10.59Neutral
- ATR5.10Low Volatility
- IndicatorValueSignal
- MFI40.45Neutral